☆ 4.7 Article

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Infectious Diseases

Remdesivir, on the road to DisCoVeRy

Iwein Gyselinck et al.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Biology

The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp

Arun Bahadur Gurung et al.

Summary: This study screened a set of FDA-approved antiviral drugs and antiviral phytocompounds, identifying Paritaprevir, Rilpivirine, and Simeprevir as the top three potential inhibitors among the drugs, and Emetine, 7,4-di-O-galloyltricetifavan, and Oleanolic acid as the top three hits among the phytocompounds.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

Khushboo Bafna et al.

Summary: Some hepatitis C virus protease inhibitor drugs can inhibit SARS-CoV-2 virus replication and enhance the antiviral activity of other drugs, but not all drugs have this effect.

CELL REPORTS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir

Ho Sing Lo et al.

Summary: Simeprevir has been identified as a promising repurposable drug for treating COVID-19, reducing SARS-CoV-2 viral load significantly and synergizing with remdesivir in vitro. Additionally, Simeprevir inhibits key viral proteins and modulates host immune responses.

ACS CENTRAL SCIENCE (2021)

添加到收藏夹

Article Microbiology

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro

Karen A. Gammeltoft et al.

Summary: This study evaluated the efficacy of hepatitis C virus NS3 protease inhibitors against SARS-CoV-2 and their interactions with remdesivir. The combination of macrocyclic protease inhibitors with remdesivir showed synergism. The study could inform the development and application of protease inhibitors for optimized antiviral treatments of COVID-19.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Infectious Diseases

Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

Marco Falcone et al.

Summary: This study aimed to evaluate the risk of hospitalization or death in patients infected by SARS-CoV2 variants of concern receiving combinations of monoclonal antibodies. The results showed that in patients infected by the SARS-CoV-2 Gamma variant, the use of bamlanivimab/etesevimab should be used with caution due to the high risk of disease progression.

INFECTIOUS DISEASES AND THERAPY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

Ren-Di Jiang et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Pauline Maisonnasse et al.

NATURE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study

Faezeh Sadat Hosseini et al.

LIFE SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors

Alfonso Trezza et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir

Sivi Ouwerkerk-Mahadevan et al.

CLINICAL PHARMACOKINETICS (2016)

添加到收藏夹

Article Microbiology

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

Thierry Verbinnen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

添加到收藏夹

Article Chemistry, Medicinal

Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor

Asa Rosenquist et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.